A Clot Retriever Device for the Treatment of Acute Ischemic Stroke and Occlusions in Peripheral Vessels

A Clot Retriever Device for the Treatment of Acute Ischemic Stroke and Occlusions in Peripheral Vessels

CLOT-SPECIFIC

CLOT-SPECIFIC

Micro-surface technology designed for a robust engagement with the clot's micro-structure

GENTLE AND SAFE

GENTLE AND SAFE

Polymer-based, non-traumatic to the vessel wall

FAST AND SIMPLE

FAST AND SIMPLE

“Over-the-Wire” technology designed for a first pass revascularization

Background

Stroke

  • Stroke is the third-leading cause of death in the U.S., Canada, Europe, and Japan1
  • The NIH estimates that stroke costs exceed $73 billion in U.S. healthcare expenditure per year1
  • In the U.S. there are 795,000 new or recurrent strokes each year2
over $1 billion

Estimated potential global market size of clot retriever devices for ischemic stroke4:

over $1 billion

Periphery

    Thrombectomy procedures are being used in cases of3:

  • Pulmonary Embolism (PE)
  • Deep Vein Thrombosis (DVT)
  • Arterio-Venous Fistulas for hemodialysis
  • Arterial Emboli
  • Acute Myocardial Infarction
1$825 million

The global market size of peripheral - thrombectomy devices in 20165:

$825 million

(Peripheral vascular: $210 million; Cardiovascular: $615 million)

About

Triticum is developing a new generation clot retriever device for the treatment of acute ischemic stroke and occlusions in peripheral vessels

  • The Triticum architecture is inspired by biological concepts
  • Made of soft polymer, using micro-surfaces technology to engage with the clot's micro-structure
  • This results in a robust but yet gentle and safe retrieval of the blood clot

Team

Close

Doron Ben Ami, MHA

Founder and Managing Director

Nadav Ben Da’at, Eng, MBA

Director of Research & Development

Seasoned executive with more than 25 years of management experience holding various leadership roles. Among them Associate Vice President, Eastern Europe and Israel region at Merck, Managing Director of the Merck’s subsidiary in Israel and the General Manager of Lundbeck, Israel. Serves as a consultant for commercial and business development to Pharma and Medical Device companies.

Udi Sadeh, MD

Medical Director

Udi Sadeh, MD

Medical Director

Doron Ben Ami, MHA

Founder and Managing Director

Head of the Intervention Neuro-Radiology Stroke Service, Imaging Division, Sourasky Medical Center, Tel Aviv, Israel. A former pilot in the Israeli Air Force.

David F. Kallmes, MD

Scientific Advisor

David F. Kallmes, MD

Scientific Advisor

Udi Sadeh, MD

Medical Director

Intervention Neuro-Radiology specialist at Mayo Clinic in Rochester, Minnesota, USA. Head of the Applied Neuroradiology Laboratory that conducts multiple preclinical research and clinical trials for stroke and other related conditions. Working on establishing, developing and validating techniques and devices testing within the Intervention Neuro-Radiology field.

Oded Shoseyov, PhD

Scientific Advisor

Oded Shoseyov, PhD

Scientific Advisor

David F. Kallmes, MD

Scientific Advisor

A member of the Nano Science and Nano Technology Center at the Hebrew University of Jerusalem. He has extensive experience in Bio-Inspired Nanocomposite materials, has more than 160 publications and 50 patents and is the scientific founder of 10 biotech companies.

David Blossom, MJ

Commercial Advisor

David Blossom, MJ

Commercial Advisor

Oded Shoseyov, PhD

Scientific Advisor

Seasoned sales and marketing executive with more than 25 years of medical device experience. Worked with several prestigious medical device companies among them Boston Scientific Corporation, Covidien/Aspect Medical Systems, Cappella Medical Systems and InspireMD.

Yuval Kahlon, D.Eng

Computational Design Advisor

Yuval Kahlon, D.Eng

Computational Design Advisor

David Blossom, MJ

Commercial Advisor

Specialist in Design Computing. Experienced in implementing state-of-the-art technology for realizing complex geometry - from large scale architectural designs to nanoscale devices. Assistant Professor of Engineering Science & Design at the Tokyo Institute of Technology, Japan.

Lindsay D’Silva, PhD

Scientific Advisor

Lindsay D’Silva, PhD

Scientific Advisor

Yuval Kahlon, D.Eng

Computational Design Advisor

st-Doctoral clinical research fellow for blood coagulation and developing novel blood biomarkers. Experienced in multiple imaging modalities (Cardiac, Ultrasonography, Scanning Electron Microscopy, and Histology).
Active as Clinical and Regulatory specialist for bringing novel medical devices to the U.S and European Markets.

Nadav Ben Da’at, Eng, MBA

Director of Research & Development

Nadav Ben Da’at, Eng, MBA

Director of Research & Development

Lindsay D’Silva, PhD

Scientific Advisor

Seasoned R&D executive with experience in the medical device industry development. Co-Established Nordson Medical R&D site in Israel and served as Sr. Technical Director.
Served as Jetprep R&D Manager from early stage to its acquisition by Cantel Medical Corporation.

Doron Ben Ami, MHA

Founder and Managing Director

Accessibility Toolbar